|   SBI-993 structure | Common Name | SBI-993 | ||
|---|---|---|---|---|
| CAS Number | 2073059-82-0 | Molecular Weight | 452.529 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C23H24N4O4S | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
| Use of SBI-993SBI-993 is an analog of SBI-477 that shows improved potency and suitable pharmacokinetic properties for in vivo bioavailability; reduces Txnip and Arrdc4 expression to a degree similar to that seen with SBI-477 in human myotubes; reduces muscle and liver TAG levels, enhances insulin signaling, and improved glucose tolerance in mice fed a high-fat diet. | 
| Name | SBI-993 | 
|---|
| Description | SBI-993 is an analog of SBI-477 that shows improved potency and suitable pharmacokinetic properties for in vivo bioavailability; reduces Txnip and Arrdc4 expression to a degree similar to that seen with SBI-477 in human myotubes; reduces muscle and liver TAG levels, enhances insulin signaling, and improved glucose tolerance in mice fed a high-fat diet. | 
|---|---|
| References | References 1. Ahn B, et al. J Clin Invest. 2016 Sep 1;126(9):3567-79. View Related Products by Target Other Targets | 
| Molecular Formula | C23H24N4O4S | 
|---|---|
| Molecular Weight | 452.529 |